Moolec Science (MLEC) Total Current Liabilities (2022 - 2025)
Moolec Science's (MLEC) quarterly Total Current Liabilities came in at $61.9 million in Q4 2025, up 858.22% year-on-year from $6.5 million in Q4 2024, and down 73.78% quarter-over-quarter from $236.1 million in Q2 2025.
Moolec Science (MLEC) Total Current Liabilities (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Total Current Liabilities across 4 years of filings, most recently posting $61.9 million for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $61.9 million, up 858.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $61.9 million (up 858.22% YoY), and the FY2025 annual result was $236.1 million, down 44.77% from the prior year.
- Total Current Liabilities came in at $61.9 million for Q4 2025 at Moolec Science, down from $236.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $427.4 million in Q2 2024 to a low of $2.9 million in Q1 2023.
- The 4-year median for Total Current Liabilities is $9.8 million (2022), against an average of $66.5 million.
- Across the five-year window, Total Current Liabilities jumped 3462.13% in 2024 and plunged 44.77% in 2025, its largest moves.
- Moolec Science's Total Current Liabilities stood at $11.3 million in 2022, then slipped by 26.57% to $8.3 million in 2023, then slipped by 22.02% to $6.5 million in 2024, then surged by 858.22% to $61.9 million in 2025.
- The last three Total Current Liabilities figures came in at $61.9 million (Q4 2025), $236.1 million (Q2 2025), and $6.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 72.86 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.88 Mn |
| Jun 30, 2025 | 236.05 Mn |
| Dec 31, 2024 | 6.46 Mn |
| Sep 30, 2024 | 7.36 Mn |
| Jun 30, 2024 | 427.40 Mn |
| Mar 31, 2024 | 7.82 Mn |
| Dec 31, 2023 | 8.28 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 2.92 Mn |
| Dec 31, 2022 | 11.28 Mn |
| Jun 30, 2022 | 4.09 Mn |